A new research-stage device aims to deliver continuous medicine via engineered cells starting in 2027.
Live Poll
Do you believe new medical innovations will effectively lower your long-term healthcare costs?
October 1, 2026
CTMC Began Pivotal Manufacturing for TIL Therapy ProgramThe Houston-based company has implemented a digital tracking system to support large-scale cell therapy production.
September 30, 2026
Baylor Researchers Identified VAV1-Degrading CompoundsThe study offers a potential new strategy to target proteins implicated in blood cancers and autoimmune diseases.
September 22, 2026
Eos SENOLYTIX Detailed MitoXcel Research in BerlinThe Houston-based firm will present preclinical data on its geropeptide candidate as it approaches a Q4 2026 merger.
